Dr Reddy's Laboratories Share Price
₹1311.40
+1.00
(+0.08%)
as on
🔔 Product Launch Alert
Dr Reddy’s launches Tegoprazan for treating acid-related gastrointestinal diseases in India, addressing a significant health need.
Dr Reddy's Laboratories Stock Performance
as on September 17, 2025 at 4:01 pm IST
Day's Low
Day's High
₹1,305.2₹1,318.2
0.47%
Downside
0.52%
Upside
52 Week's Low
52 Week's High
₹1,020₹1,405.922.22%
Downside
7.21%
Upside
Dr Reddy's Laboratories share price movements today
- Previous Close
- ₹1,310.40
- Open
- ₹1,317.00
- Volume
- 7.17L
- Upper Circuit
- ₹1,441.40
- Lower Circuit
- ₹1,179.40
- Day's Low - High
- ₹1,305.2 - ₹1,318.2
- 52 Week Low - High
- ₹1,020 - ₹1,405.9
Dr Reddy's Laboratories Historical Returns
- 1 Month Return
- + 3.78 %
- 3 Month Return
- -0.64 %
- 1 Year Return
- -1.2 %
- 3 Year Return
- + 59.84 %
- 5 Year Return
- + 35.73 %
Dr Reddy's Laboratories Fundamentals
as on September 17, 2025 at 4:01 pm IST
Market Cap
₹1,09,366.94 Cr
Return on Equity (ROE)
20.15
PE Ratio (TTM)
19.21
Return on capital employed (ROCE)
25.47
Industry PE ratio
42.14
Beta (LTM)
0.66
P/B Ratio
3.31
Dividend Yield
0.7
PEG Ratio
14.23
Quarterly Earnings Growth YOY
1.26
EPS (TTM)
68.65
Sector
Pharmaceuticals
Book Value
402.27
Technical Analysis
Bullish
View Technical Analysis
Dr Reddy's Laboratories Stock Valuation
as on September 17, 2025 at 4:01 pm IST
Dr Reddy's Laboratories in the last 5 years
Lowest (3.37x)
October 27, 2019
Today (19.21x)
September 16, 2025
Industry (42.14x)
September 16, 2025
Highest (53.88x)
December 18, 2020
Today’s Price to Earnings Ratio: 19.21x
Dr Reddys Laboratories Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Dr Reddy's Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 1,09,366.94 | 7.15% | 0.57 | 5,725 | 32,643 | |
| HOLD | 1,61,922.56 | 17.99% | 0.50 | 2,191 | 9,360 | |
| BUY | 1,19,652.01 | 29.77% | 0.66 | 1,911 | 11,516 | |
| BUY | 48,157.43 | -3.71% | 0.78 | 1,429 | 15,261 | |
| HOLD | 33,310.45 | 2.22% | 0.53 | 698 | 5,616 |
Analyst Recommendation on Dr Reddy's Laboratories Stock
Based on 38 analysts
30.77%
Buy
28.21%
Hold
41.03%
Sell
Based on 38 analysts, 41.03% of analysts recommend a 'HOLD' rating for Dr Reddy's Laboratories. Average target price of ₹1287.37
Source: S&P Global Market Intelligence
Dr Reddy's Laboratories Share Price Target
Get share price movements and forecasts by analysts on Dr Reddy's Laboratories.
What analysts predicted
-1.76%DOWNSIDE
Target Price
₹1287.37
Current Price
₹1311.4
Analyzed by
38 Analysts
High
₹1660
Target
₹1287.37
Low
₹990
Dr Reddy's Laboratories target price ₹1287.37, a slight downside of -1.76% compared to current price of ₹1311.4. According to 38 analysts rating.
Source: S&P Global Market Intelligence
Dr Reddy's Laboratories Stock's Interest Amongst Investors
Investment in Dr Reddys Laboratories Ltd Shares on INDmoney has dropped by -20.11% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Dr Reddys Laboratories Ltd Stock has increased by 5% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:5% versus previous 30 day period
Dr Reddys Laboratories Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Dr Reddys Laboratories Ltd Annual Profit & Loss
Figures in Rupees Crores
Dr Reddys Laboratories Ltd Cash Flow
Figures in Rupees Crores
Dr Reddy's Laboratories Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Dr Reddy's Laboratories Stock
Check out the Mutual Funds with significant holdings in Dr Reddy's Laboratories.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 Parag Parikh Flexi Cap Direct Growth | 1.27% | 11632943 | |
 ICICI Prudential Value Fund Direct Plan Growth | 2.19% | 9322942 | |
 Nippon India Large Cap Fund - Direct Plan - Growth Plan | 1.5% | 5357429 | |
ICICI Prudential Balanced Advantage Fund Direct Plan Growth | 0.94% | 4886509 | |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth | 9.47% | 4633059 |
Dr Reddy's Laboratories Earnings and Dividends
View detailed summary of the earnings and dividend history of Dr Reddy's Laboratories.
Dr Reddys Laboratories Ltd Earnings Results
Dr Reddys Laboratories Ltd’s net profit jumped 1.85% since last year same period to ₹1,418.10Cr in the Q1 2025-2026. On a quarterly growth basis, Dr Reddys Laboratories Ltd has generated -11% fall in its net profits since last 3-months.
Read More about Earnings ResultsDr Reddys Laboratories Ltd Dividends May,2025
In the quarter ending March 2025, Dr Reddys Laboratories Ltd has declared dividend of ₹8.00 per share on 09 May 2025 - translating a dividend yield of 0.61%.
Read More about Dividends
Indices Featuring Dr Reddy's Laboratories Stock
Check stock indices that include Dr Reddy's Laboratories.
Insights on Dr Reddys Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 month, DRREDDY stock has moved up by 3.8%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 12.89% to 13.61% in Jun 2025 quarter
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 26.64% of holdings in Jun 2025 quarter
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 10.15% to 10.00% in Jun 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 25.75% to 25.32% in Jun 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 1.59K Cr → 1.41K Cr (in ₹), with an average decrease of 11.0% per quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 9.05K Cr → 8.86K Cr (in ₹), with an average decrease of 2.1% per quarter
Dr Reddy's Laboratories Stock Futures & Options Contracts
View the latest movement in Dr Reddy's Laboratories Futures & Options, including strike prices, expiry dates, and percentage changes.
Dr Reddy's Laboratories Options
Dr Reddy's Laboratories Futures
About Dr Reddys Laboratories Ltd
Dr Reddy's Laboratories Ltd has a diverse portfolio of products and services, including prescription drugs, generic drugs, over-the-counter drugs, active pharmaceutical ingredients, biotechnology products, and nutraceuticals. Its most popular products include antibiotics, anti-infectives, anti-diabetics, anti-cancer, cardiovascular, gastrointestinal, and dermatology products. Some of its popular brands include Omez, Ciprocin, and Revital. It also has a strong presence in the generics market with its brands such as Reditux and Reditux-D.
Revenue: ₹8,545.20Cr as on June 2025 (Q1 FY26)
Net Profit: ₹1,409.90Cr as on June 2025 (Q1 FY26)
Listing date: 03 Nov, 1994
Chairperson Name: K Satish Reddy
| Organisation | Dr Reddys Laboratories Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | K Satish Reddy |
| E-voting on shares | Click here to vote |
FAQs
What is Dr Reddy's Laboratories share price today?
Dr Reddy's Laboratories share price today stands at ₹1311.4 as on at the close of the market. Dr Reddy's Laboratories share today touched a day high of ₹1318.2 and a low of ₹1305.2.
What is the 52 week high and 52 week low range for Dr Reddy's Laboratories share?
Dr Reddy's Laboratories touched a 52 week high of ₹1405.9 and a 52 week low of ₹1020. Dr Reddy's Laboratories share price today i.e. is closed at ₹1311.4, which is -6.72% down from its 52 week high and 28.57% up from its 52 week low.
What is Dr Reddy's Laboratories's market capitalisation today?
Dr Reddy's Laboratories market capitalisation is ₹1,09,366.94 Cr as on .
How to buy Dr Reddy's Laboratories shares?
To buy Dr Reddy's Laboratories shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for DRREDDY or Dr Reddys Laboratories Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Dr Reddy's Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Dr Reddy's Laboratories trading volume today?
Dr Reddy's Laboratories trading volume is 7.17L as on . This means that 7.17L shares of Dr Reddy's Laboratories were bought and sold on the stock market during today's trading session.